1. Home
  2. AQST vs PANL Comparison

AQST vs PANL Comparison

Compare AQST & PANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AQST
  • PANL
  • Stock Information
  • Founded
  • AQST 2004
  • PANL 1996
  • Country
  • AQST United States
  • PANL United States
  • Employees
  • AQST N/A
  • PANL N/A
  • Industry
  • AQST Biotechnology: Pharmaceutical Preparations
  • PANL Marine Transportation
  • Sector
  • AQST Health Care
  • PANL Consumer Discretionary
  • Exchange
  • AQST Nasdaq
  • PANL Nasdaq
  • Market Cap
  • AQST 390.4M
  • PANL 332.0M
  • IPO Year
  • AQST 2018
  • PANL N/A
  • Fundamental
  • Price
  • AQST $3.96
  • PANL $4.75
  • Analyst Decision
  • AQST Strong Buy
  • PANL
  • Analyst Count
  • AQST 7
  • PANL 0
  • Target Price
  • AQST $11.29
  • PANL N/A
  • AVG Volume (30 Days)
  • AQST 1.1M
  • PANL 192.5K
  • Earning Date
  • AQST 08-11-2025
  • PANL 08-15-2025
  • Dividend Yield
  • AQST N/A
  • PANL 4.23%
  • EPS Growth
  • AQST N/A
  • PANL N/A
  • EPS
  • AQST N/A
  • PANL 0.30
  • Revenue
  • AQST $54,228,000.00
  • PANL $554,589,579.00
  • Revenue This Year
  • AQST N/A
  • PANL $4.72
  • Revenue Next Year
  • AQST $51.62
  • PANL $16.57
  • P/E Ratio
  • AQST N/A
  • PANL $15.53
  • Revenue Growth
  • AQST 5.29
  • PANL 13.11
  • 52 Week Low
  • AQST $2.12
  • PANL $3.93
  • 52 Week High
  • AQST $5.80
  • PANL $7.50
  • Technical
  • Relative Strength Index (RSI)
  • AQST 50.64
  • PANL 35.51
  • Support Level
  • AQST $3.73
  • PANL $4.90
  • Resistance Level
  • AQST $4.10
  • PANL $5.20
  • Average True Range (ATR)
  • AQST 0.22
  • PANL 0.15
  • MACD
  • AQST -0.07
  • PANL -0.06
  • Stochastic Oscillator
  • AQST 17.42
  • PANL 16.25

About AQST Aquestive Therapeutics Inc.

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

About PANL Pangaea Logistics Solutions Ltd.

Pangaea Logistics Solutions Ltd and its subsidiaries provide seaborne drybulk logistics and transportation services. It transports various drybulk cargoes including grains, coal, iron, ore, pig, iron, hot briquetted iron, bauxite, alumina, cement clinker, dolomite, and limestone. The company provides ocean transportation services to clients utilizing an ocean-going fleet of motor vessels in the Handymax, Supramax, Ultramax, Panamax, and Post-Panamax segments. Its services include cargo loading, cargo discharge, vessel chartering, voyage planning, and technical vessel management. The company derives all of its revenues from contracts of affreightment, voyage charters and time charters. Geographically, it derives key revenue from the United States, followed by Canada, Germany, and others.

Share on Social Networks: